Welcome to our dedicated page for Agronomics news (Ticker: AGNMF), a resource for investors and traders seeking the latest updates and insights on Agronomics stock.
Agronomics Ltd reports developments tied to its listed clean-food investment portfolio, including net asset value updates, interim financial results, share issuance, total voting rights and director dealing notifications under UK market-abuse disclosure rules.
Company announcements also describe investments and valuation movements across portfolio companies working in precision fermentation, cultivated seafood, animal-free dairy proteins and related food biotechnology. Recurring items include funding rounds, regulatory clearances, commercial-scale manufacturing initiatives and portfolio company status changes, including orderly wind-downs when an investment is written down.
Agronomics (OTC:AGNMF) announced that portfolio company Liberation Bioindustries closed the first tranche of its Series A1 equity round on 19 December 2025.
Liberation is constructing a 600,000‑liter commercial precision‑fermentation facility to produce protein and bio‑based ingredients. Agronomics converted its convertible loan notes into Series A1 shares, increasing its A1 shareholding from 6,834,147 to 16,538,437. Agronomics has invested US$27.0m to date; the investment is now carried at US$46.8m (c. £35m), a recorded uplift of US$2.5m. The position represents approximately 23% of Agronomics' net asset value as of 30 Sep 2025. New Agrarian Company will invest US$2.5m in the round.
Agronomics (AGNMF) reports that portfolio company Geltor received a US FDA "No Questions" letter confirming GRAS status for PrimaColl®, the first biodesigned vegan collagen polypeptide cleared for food use.
PrimaColl® is commercially scaled, designed to mimic avian Type 21 collagen, and positioned for both ingestible and topical markets; topical availability is global. Agronomics has invested £7.2 million in Geltor to date, with the holding currently carried at approximately £237,617 (~0.16% of Agronomics NAV of £145.3m as of 30 June 2025).
Agronomics (LSE:ANIC) announced that its portfolio company, Clean Food Group (CFG), has acquired the assets of Algal Omega 3 Ltd, gaining access to 1 million liters of fermentation capacity in Liverpool. The acquisition positions CFG as one of the world's largest manufacturers of yeast fermentation-derived sustainable oils and fats.
The 12-acre Liverpool facility includes R&D capabilities and has already demonstrated successful commercial-scale production with 2 tons of oil in a recent fermentation run. CFG recently received regulatory approval for its CLEAN Oil™ 25 product for cosmetic use in the UK, Europe, and US. The company aims to address a $20 billion market opportunity and plans a Series A funding round in H1 2026.
Agronomics' investment of £1.6 million in CFG is currently valued at £6.9 million, representing approximately 4.8% of Agronomics' last stated Net Asset Value as of June 30, 2025.
Onego Bio, a portfolio company of Agronomics (AGNMF), has achieved a significant regulatory milestone as the FDA issued a "no questions" letter regarding the GRAS status of its Bioalbumen® product. This egg protein alternative, produced through precision fermentation, can now be used as a dietary protein source and functional ingredient in various food applications.
The company plans to construct its flagship production facility in Jefferson County, Wisconsin, to scale manufacturing. Agronomics has invested £7.1 million in Onego Bio, with the position currently valued at £11.2 million, representing approximately 7.5% of Agronomics' Net Asset Value as of June 30, 2025.
Clean Food Group (CFG), a portfolio company of Agronomics (AGNMF), has achieved a significant milestone by receiving regulatory approval for its CLEAN Oil™ 25 product as a cosmetic ingredient in the UK, Europe, and United States. The precision-fermented oil offers a sustainable alternative to palm oil, which is currently used in 70% of cosmetic products.
Developed in collaboration with THG LABS and Croda International plc, this breakthrough targets the global personal care and cosmetics sector, projected to reach $776.35 billion by 2030. Agronomics' investment of £1.6 million in CFG is currently valued at £6.9 million, representing approximately 4.8% of Agronomics' last stated Net Asset Value as of June 2025.
Agronomics Limited (AGNMF) reported its unaudited Net Asset Value (NAV) as of June 30, 2025, at 14.40 pence per share, representing a 2.8% decrease from March 2025. The company's total Net Assets stood at £145.3 million, including £141.8 million in investments and £3.6 million in cash.
The quarter saw a £4.1 million decline in NAV, primarily due to unrealized FX losses of £4.2 million from currency fluctuations. Despite this, portfolio companies achieved significant milestones, including BlueNalu's expanded partnership with Nomad Foods, Liberation Bioindustries's strategic partnership with NEOM, and Meatable's collaboration with TruMeat for cultivated meat commercialization.
Agronomics Limited (AGNMF) reported its unaudited Net Asset Value (NAV) as of March 31, 2025, at 14.81 pence per share, representing a 0.80% decrease from December 2024. The company's Net Assets stand at £149 million, including £146 million in investments and £4 million in cash. The current share price of 7.15 pence represents a 52% discount to NAV.
Key portfolio developments include: Liberation Labs securing a $50.5M convertible note raise, Formo Bio obtaining a €35M EIB loan, and Solar Foods receiving €10M in government funding. Notable milestone: Good Dog Food (Meatly) became the first company to sell cultivated meat for pet food in Europe. The quarter saw a £1.2M NAV decline, mainly due to FX losses of £2.5M, partially offset by a £1.3M value increase in Solar Foods holding.